Erika Bartel

Title: The Innovative Contributions of Erika Bartel

Introduction

Erika Bartel is a notable inventor based in La Plata, Buenos Aires, Argentina. She has made significant strides in the field of vaccine development, particularly focusing on the prevention of infections. Her work has implications for public health and showcases her dedication to scientific advancement.

Latest Patents

Erika Bartel holds 1 patent for a vaccine designed to prevent infections. This innovative vaccine comprises at least outer membrane vesicles (OMVs) and various excipients and/or adjuvants. The formulation may include adjuvants such as aluminum hydroxide and immunogens like tetanus toxoid and diphtheria toxoid. The vaccine is engineered to deliver between 3 to 20 µg per dose of OMVs and a specific amount of lipopolysaccharide per dose. This development highlights her commitment to enhancing vaccine efficacy and safety.

Career Highlights

Throughout her career, Erika Bartel has been associated with esteemed institutions such as the National Scientific and Technical Research Council (CONICET) and the National University of La Plata. Her work in these organizations has allowed her to contribute to significant research initiatives and foster innovation in the field of immunology.

Collaborations

Erika has collaborated with notable colleagues, including Daniela Hozbor and Daniela Bottero. These partnerships have enriched her research and expanded the impact of her work in vaccine development.

Conclusion

Erika Bartel's contributions to vaccine innovation reflect her expertise and commitment to improving public health. Her patent and collaborations underscore her role as a leading figure in the scientific community.